Anti — Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis

[1]  J. Becker,et al.  Proctocolectomy with ileoanal anastomosis , 2004, Journal of Gastrointestinal Surgery.

[2]  S. Targan,et al.  Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis , 1995, Journal of Clinical Immunology.

[3]  H. Drummond,et al.  Disease Location, Anti-Saccharomyces cerevisiae Antibody, and NOD2/CARD15 Genotype Influence the Progression of Disease Behavior in Crohn’s Disease , 2004, Inflammatory bowel diseases.

[4]  B. Sands,et al.  A male with a pelvic mass , 2004, Gut.

[5]  R. Odze Pathology of indeterminate colitis. , 2004, Journal of clinical gastroenterology.

[6]  H. Drummond,et al.  Anti‐Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations , 2004, Clinical and experimental immunology.

[7]  C. Bodian,et al.  Are pANCA, ASCA, or Cytokine Gene Polymorphisms Associated with Pouchitis? Long-term Follow-up in 102 Ulcerative Colitis Patients , 2004, American Journal of Gastroenterology.

[8]  Elena A. Manilich,et al.  Quantification of Risk for Pouch Failure After Ileal Pouch Anal Anastomosis Surgery , 2003, Annals of surgery.

[9]  R. Nakamura,et al.  Advances in clinical laboratory tests for inflammatory bowel disease. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[10]  K. Higuchi,et al.  Cross‐reactivity of yeast antigens in human colon and peripheral leukocytes , 2003, The Journal of pathology.

[11]  K. Cotman,et al.  Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis. , 2003, Journal of pediatric surgery.

[12]  P. Rutgeerts,et al.  The value of serologic markers in indeterminate colitis: a prospective follow-up study. , 2003, Gastroenterology.

[13]  M. Hoelscher,et al.  Anti-Saccharomyces cerevisiae Antibodies in Patients with Inflammatory Bowel Disease and Their First-Degree Relatives: Potential Clinical Value , 2002, Digestion.

[14]  H. Järvinen,et al.  Cumulative Failure Rate of Ileal Pouch-Anal Anastomosis and Quality of Life After Failure , 2002, Diseases of the colon and rectum.

[15]  C. Doglioni,et al.  [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease]. , 2002, Recenti progressi in medicina.

[16]  A. Šedivá,et al.  Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. , 2002, Clinical immunology.

[17]  H. Järvinen,et al.  Familial and Sporadic Inflammatory Bowel Disease: Comparison of Clinical Features and Serological Markers in a Genetically Homogeneous Population , 2002, Scandinavian journal of gastroenterology.

[18]  M. T. Abreu-Martin,et al.  High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis , 2001, Gut.

[19]  S. Targan,et al.  Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease , 2001, American Journal of Gastroenterology.

[20]  B. Flourié,et al.  Outcome of ileal pouch after secondary diagnosis of Crohn’s disease , 2000, International Journal of Colorectal Disease.

[21]  A. Zinsmeister,et al.  Antineutrophil cytoplasmic antibody subtypes in children and adolescents after ileal pouch-anal anastomosis for ulcerative colitis. , 1998, Journal of pediatric gastroenterology and nutrition.

[22]  R. Ricketts Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis , 1996 .

[23]  S. Targan,et al.  A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. , 1990, The Journal of allergy and clinical immunology.